Industry CME Affiliates Would Be Restricted Under Accrediting Proposal
Executive Summary
Continuing medical education providers affiliated with drug manufacturers would be prohibited from conducting CME programs in therapeutic categories where the manufacturer has products under a proposed revision to the Accreditation Council for Continuing Medical Education's standards for providers
You may also be interested in...
Pharma Should Be Excluded From Guideline Development – NEJM Editorial
Standards for the development and adoption of treatment guidelines should be established in light of efforts by industry to manipulate guidelines for commercial purposes, NIH Critical Care Medicine Department senior investigators assert
Pharma Should Be Excluded From Guideline Development – NEJM Editorial
Standards for the development and adoption of treatment guidelines should be established in light of efforts by industry to manipulate guidelines for commercial purposes, NIH Critical Care Medicine Department senior investigators assert
CME Accrediting Proposal Should Clearly Define Conflict Of Interest – PhRMA
The Accreditation Council for Continuing Medical Education's proposed guidelines should include a clear definition of conflict for CME providers, the Pharmaceutical Research & Manufacturers of America says